Arcus Biosciences, Inc. (RCUS)
21.97
-0.73
(-3.22%)
USD |
NYSE |
Mar 13, 16:00
21.95
-0.02
(-0.09%)
Pre-Market: 20:00
Arcus Biosciences EPS Diluted (Quarterly) : -0.8945 for Dec. 31, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Gilead Sciences, Inc. | 1.742 |
| Eli Lilly & Co. | 7.024 |
| Merck & Co., Inc. | 1.191 |
| ACADIA Pharmaceuticals, Inc. | 1.596 |
| Regeneron Pharmaceuticals, Inc. | 7.857 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -106.00M |
| Revenue (Quarterly) | 33.00M |
| Total Expenses (Quarterly) | 139.00M |
| Enterprise Value | 1.971B |
| Gross Profit Margin (Quarterly) | 90.91% |
| Profit Margin (Quarterly) | -321.2% |
| Earnings Yield | -15.02% |
| Normalized Earnings Yield | -15.02 |